https://www.bioworld.com/articles/720517-avenzo-gains-ind-clearance-for-cdk4-inhibitor?v=preview
Avenzo gains IND clearance for CDK4 inhibitor | BioWorld
Avenzo Therapeutics Inc. has gained IND clearance from the FDA for AVZO-023 (formerly ARTS-023), a CDK4-selective inhibitor. The company also announced it has...
avenzogainsindclearanceinhibitor